Skip to main content

Advertisement

Log in

The ‘Insertion/Deletion’ Polymorphism, rs4340 and Diabetes Risk: A Pilot Study from a Hospital Cohort

  • Original Research Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

The insertion/deletion, I/D polymorphism, in the gene encoding Angiotensin Converting Enzyme, ACE is a popular genetic marker for cardiovascular disease, CVD. With alarming rise in diabetes, the risk of CVD among Indian subjects is further enhanced. The present study explored the role of ACE I/D polymorphism, rs4340 as a genetic marker and its association with diabetes. Genomic DNA, isolated from a cohort of 410 urban subjects attending our hospital, was genotyped using polymerase chain reaction followed by electrophoresis. Among the subjects, 84 had type-2 diabetes and 68 had hypertension while 258 were free from these risk factors. Majority (57/84) of diabetic subjects were also suffering from hypertension. Genotype frequencies of ACE I/D polymorphism, of diabetic (84) patients were not different from that of non-diabetic subjects (258). In sharp contrast, we found significant differences, in genotype frequencies of women with diabetes (n = 38) compared to non-diabetic women (70). Diabetic women had significantly higher prevalence of the high risk ‘D’ allele. Analysis of odds ratio, OR revealed that women with ‘D/D’ genotype, exhibited threefold risk (OR 3.12, 95% CI 1.21—8.05; p = 0.018) of diabetes, in the recessive model (D/D vs I/I + I/D). Further when we analysed Odds ratio of diabetic women (8) who were free from hypertension, the results revealed even a greater, 6- fold (OR 6.0, 95% CI 1.29–27.96, p = 0.027) risk of diabetes for D/D homozygous women (D/D vs I/I + I/D). These results suggest ‘sex-specific’ association of ACE ‘I/D’ polymorphism, with type-2 diabetes, affecting women while there was no influence observed among men. In view of the increased cardiovascular mortality among Indians, data from our pilot study if confirmed in a larger cohort, could add value to our future intervention efforts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Luhar S, Kondal D, Jones R, Anjana RM, Patel SA, Kinra S, Clarke L, Ali MK, Prabhakaran D, Kadir MM, Tandon N, Mohan V, Venkat Narayan KM. Lifetime risk of diabetes in metropolitan cities in India. Diabetologia. 2021;64:521–9.

    Article  PubMed  Google Scholar 

  2. Marie Loh, Zhang W, Ng HK, Schmid K, Lamri A et al. Identification of genetic effects underlying type 2 diabetes in South Asian and European populations. Communication Biology 2022;5:329. https://doi.org/10.1038/s42003-022-03248-5. www.nature.com/commsbio

  3. Crisan D, Carr J. Angiotensin I converting enzyme, genotype and disease associations. J Mol diagn. 2000;2(3):105–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Rigat B, Hubert C, Gelas F, Cambien F, Corvol P, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, et al. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet. 1996;58(6):1268–78.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Morris BJ. Hypothesis: an angiotensin converting enzyme genotype, present in one in three Caucasians, is associated with increased mortality rate. Clin Exp Pharmacol Physio. 1996;23(1):1–10.

    Article  CAS  Google Scholar 

  7. Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardio. 2012;4(4):112–20.

    Article  Google Scholar 

  8. Mani D, Chinniah R, Ravi P, Swaminathan K, Janarthanan RA, et al. Predisposition of angiotensin-converting enzyme deletion/deletion genotype to coronary artery disease with type 2 diabetes mellitus in South India. Indian J Endocrinol Metab. 2017;21(6):882–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Mahwish UN, Ponnaluri KC, Heera B, Alavala SR, Devi KR, et al. Link between ACE I/D gene polymorphism and dyslipidemia in diabetic nephropathy: a case-control study from Hyderabad. India Indian J Nephrol. 2020;30(2):77–84.

    Article  PubMed  Google Scholar 

  10. Moorthy N, Ramegouda KS, Jain S, Bharath G, Sinha A, Nanjappa MC, Christopher R. Role of angiotensin converting enzyme gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction. IJC Heart Vasc. 2021;32:1–7.

    Google Scholar 

  11. Siddharth K, Kapur S, Ram CV. Angiotensin converting enzyme gene polymorphism and hypertension: no ace yet in the pack of cards. J Assoc Phys India. 2012;60:9–10.

    CAS  Google Scholar 

  12. Dwivedi M, Laddha NC, Imran M, Ansarullah BP, Ramachandran AV, Misra A, Yadav AM, Begum R. ACE gene I/D polymorphism in type 2 diabetes: the Gujarat population. Br J Diab Vasc Dis Lett. 2011;11:153.

    Article  CAS  Google Scholar 

  13. Jhawat V, Gupta S, Agarwal BK, Roy P, Saini V. Angiotensin converting enzyme gene insertion/deletion polymorphism is not responsible for antihypertensive therapy induced new onset of type 2 diabetes in essential hypertension clinical medicine insights. Endocrinol Diab. 2019;12:1–10.

    Google Scholar 

  14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Maurya R, Kumar B, Sundar S. Evaluation of salt-out method for the isolation of DNA from whole blood: a pathological approach of DNA based diagnosis. Int J Lifesc Bt Pharm Res. 2013;2(2):53–7.

    CAS  Google Scholar 

  16. Lindpainter K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332(11):706–11.

    Article  Google Scholar 

  17. Sudhir N, Badaruddoza A. No evidence for association between ACE gene insertion (I)/deletion (D) polymorphism and hypertension in North Indian Punjabi population. Int J Hum Genet. 2012;12(3):179–85.

    Article  Google Scholar 

  18. Pinheiro DS, Santos RS, Jardim PCBV, Silva EG, Reis AAS, et al. The combination of ACE I/D and ACE2 G8790A polymorphism reveals susceptibility to hypertension. PLoS ONE. 2019;14(8): e0221248.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Shanmuganathan R, Kumaresan R, Giri P. Prevalence of angiotensin converting enzyme insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease. J Postgrad Med. 2015;61(4):230–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ned RM, Yesupriya A, Imperatore G, Smelser DT, Moonesinghe R, et al. The ACE I/D polymorphism in US adults: limited evidence of association with hypertension-related traits and sex-specific effects by race/ethnicity. Am J Hypertens. 2012;25(2):209–15.

    Article  CAS  PubMed  Google Scholar 

  21. Garcia A, Bey A, Diaz D, Perez J, Diaz G, et al. Influence of ACE gene I/D polymorphism on cardiometabolic risk, maximat fat oxidation, cardiorespiratory fitness, diet and physical activity in young adults. Int J Environ Res Public Health. 2021;18(7):3443.

    Article  Google Scholar 

  22. Gonzalez P, Garcia R, Reyna L, Grau G, Gonsalez R, et al. Androgen receptor gene polymorphism influence fat accumulation: a longitudinal study from adolescence to adult age. Scand J Med Sci Sport. 2016;26(11):1313–20.

    Article  Google Scholar 

  23. Niu W, Qi Y, Gao P, Zhu D. Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis. Endocr J. 2010;57(5):431–8.

    Article  CAS  PubMed  Google Scholar 

  24. Wyawahare M, Neelamegam R, Vilvanathan S, Soundravally R, Das AK, et al. Association of angiotensin-converting enzyme gene polymorphisms and nephropathy in diabetic patients at a tertiary care centre in south India. Exp Clin Endocrinol Diabetes. 2017;10:1–5.

    CAS  Google Scholar 

Download references

Acknowledgements

The authors are grateful to Dr. Vikrant Bhor (from NIRRH) for his help in statistical analysis. We would like to thank Ms. Carmin Fernandes for her guidance in recording the patient's medical history and collection of blood samples

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Rosalind Marita.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shah, M., Gupta, A., Talekar, M. et al. The ‘Insertion/Deletion’ Polymorphism, rs4340 and Diabetes Risk: A Pilot Study from a Hospital Cohort. Ind J Clin Biochem 39, 124–129 (2024). https://doi.org/10.1007/s12291-022-01076-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-022-01076-2

Keywords

Navigation